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The study aimed to identify the phenolic compounds present in Centella asiatica (L.)
(C. asiatica) extract and evaluate the respective antioxidant potential as well as its
cholesterol-lowering effects in the experimental animal model. Herein, the antioxidant
potential of extracts was assessed by its free radical scavenging activity such as 2,
2-diphenyl -1- picrylhydrazyl as well as reducing capability. The anti-hyperlipidemic
effects of C. asiatica extract (CAE) were evaluated in high cholesterol-fed (HCF) rats
for 4 weeks, where different concentrations of extracts (0.25, 0.5, and 1 g/kg/day) were
orally administrated daily. Lipid and antioxidant profiles, including total cholesterol (TC),
triglyceride (TG), low density lipoprotein cholesterol (LDL-C), high density lipoprotein
cholesterol (HDL-C) and superoxide dismutase (SOD), together with the indices of
hepatic functions were also examined. C. asiatica revealed excellent free radical
scavenging activity as revealed by 2-2- diphenyl-1-picryl-hydrazyl (DPPH) assay, with
the IC50 values (9.62 ± 0.88 µg/mL). Furthermore, C. asiatica extracts and fenofibrate
remarkably lowered the level of TC, TG, LDL-C, and showed elevated levels of HDL-
C, SOD. The histopathological observations further demonstrated clear differentiation
and structural changes in liver of HCF and CAE treated group. Furthermore, gulonic
acid, ferulic acid, kaempferol, chlorogenic acid, and asiatic acid were identified to be
the major components which might be responsible for the antioxidant activity of the
C. asiatica extract as evidenced from an ultra-high performance liquid chromatography–
mass spectrometer. Taken together, these results signifies the excellent antioxidant and
anti-hyperlipidemic properties of C. asiatica leaf extracts, which might be useful for the
treatment of oxidative-stress related diseases such as hyperlipidemia.
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INTRODUCTION
Oxidative stress (OS) is essentially an imbalance between the production of free radicals, such
as superoxide (O−2 ), hydroxyl (OH), and peroxyl (ROO) radicals and the ability of the body to
counteract or detoxify their harmful effects through neutralization by antioxidants. OS leads to
many chronic and degenerative diseases such as cancer, atherosclerosis, Parkinson’s, Alzheimer’s,
diabetes, neurodegenerative disorders, and aging (Yu, 1994; Raghuveer and Tandon, 2009).
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Overproduction of these radicals can lead to the above mentioned
disorders with as a consequence of “OS/oxidative damage.” In
earlier reports, various synthetic antioxidant compounds such
as butylated hydroxyanisole (BHA), butylated hydroxytoluene
(BHT), tertiary butylhydroquinone (TBHQ), and propyl gallate
(PG) have shown effectiveness in the human body against
oxidative damage caused by free radicals (Issa et al., 2006; Kaliora
et al., 2006). However, the utilization of synthetic antioxidants is
restricted now a day due to their toxicity and undesirable effects
on human health (Sasaki et al., 2002; Bajpai et al., 2014).
Hyperlipidemia is represented by elevated levels of plasma
lipid, serum cholesterol, and triglyceride (TG) and remains one
of the major risk factors for coronary heart diseases (CHD),
especially, the increased plasma low-density lipoprotein level
can accelerate atherosclerosis (Arsenault et al., 2009; Harchaoui
et al., 2009; de Lemos et al., 2010; Berry et al., 2012; Ma et al.,
2012). The excessive intake of exogenous TG and cholesterol is
associated with an elevated risk of atherosclerotic disease, which
is regarded as a lipid storage disease with arterial deposition
of cholesterol, endothelial injury and platelet aggregation (Liao
et al., 2000). Several research groups have demonstrated
that with the improvement of serum lipid profile, such as
total cholesterol (TC), TG, and (TC-HDL-C)/HDL-c decreases
liver lipid accumulation and lipid absorption. Therefore, the
increasing serum/liver antioxidant capacity represents the most
effective way for combating the occurrence of cardiovascular
or liver disorders (Yang D.J. et al., 2010; Yang S.F. et al., 2010;
Chang et al., 2011; Hsu et al., 2011; Liu et al., 2012; Lin et al.,
2013).
Medicinal plants are rich sources of important metabolites,
which are potential sources of antioxidant, antimicrobial, anti-
inflammatory, and anticancer activities (Hernandez et al., 2000;
Polya, 2003; Maruthanila et al., 2014). The utilization of herbal
medicine in treating infectious diseases have been practiced
for 1000s of years and will continue to provide mankind
with new remedies (Cragg and Newman, 2007). Earlier reports
have demonstrated a distinct correlation between the higher
intake of plant foods and lower risk of mortality from diseases
(Chidambaram et al., 2013). Recent interest has escalated in the
finding antioxidant properties of natural origin plants due to their
superior safety and consumer acceptability (Gorinstein et al.,
2003). Additionally, approximately 60% of the commercially
available anti-tumor and anti-infective agents are natural in
origin (Shridhar et al., 2009). North Eastern (NE) region of
India represents one of the mega biodiversity hotspots of the
world and harbors a large number of medicinal plants. Around
80% of the population relies mainly on traditional medicine
for their primary healthcare needs due to the high cost of
western medicine (Rai and Lalramnghinglova, 2010; Lokho,
2012).
Centella asiatica (Family, Apiaceae) is commonly known as
Centella and Gotu kola. It is native to India and other parts
of Asia such as China, Sri Lanka, Nepal and Madagascar and
has been utilized in folk medicine in different countries (Gohil
et al., 2010). C. asiatica has been reported for the treatment
of varicose veins, chronic venous insufficiency, psoriasis, minor
wounds, analgesic, and anti-inflammatory effects (Pronprapa
et al., 2010; Somboonwong et al., 2012). The primary constituents
of C. asiatica are saponins (also called triterpenoids), which
include asiaticosides, brahmoside, asiatic acid, and brahmic acid
(madecassic acid) (Joshi and Chaturvedi, 2013). These triterpene
saponins and their sapogenins are mainly responsible for the
wound healing and vascular effects, which acts by inhibiting
the production of collagen at the wound site (Seevaratna et al.,
2012; Joshi and Chaturvedi, 2013). Other components isolated
from C. asiatica, such as brahmoside and brahminoside, may be
responsible for central nervous system (CNS) and uterorelaxant
actions, but are yet to be confirmed by clinical studies (Orhan,
2012; Seevaratna et al., 2012; Joshi and Chaturvedi, 2013). In
a recent study, researchers have utilized C. asiatica for wound
healing activities of different extracts in partial-thickness burn
wound models in rats (Somboonwong et al., 2012). In our
previous report, we have identified and characterized phenolic
compounds in C. asiatica by using UHPLC-MS/MS (Kumari
et al., 2016). However, its anti-hyperlipidemic activities in rat fed
with high-fat diet have not been documented yet from NE region.
Therefore, we have designed this study in order to demonstrate
the anti-hyperlipidemic activity of C. asiatica extracts in normal
and high cholesterol-fed (HCF)-induced hyperlipidemic rat,
which is the crucial factor in the treatment of oxidative-stress
related diseases.
MATERIALS AND METHODS
Sample Collection
Centella asiatica plant was collected from the Sixmile, Guwahati,
and Kamrup district of Assam (situated in between 25◦ 43′–
26◦ 53′ North latitude and 90◦ 39′–92◦ 11′ East latitude in the
month of June to August 2015). The plant was authenticated and
reconfirmed in the Department of Botany, Gauhati University,
Assam. Herbarium C. asiatica (voucher specimens number:
IASST/BCCS/HNO21/2013), was deposited in the Life Science
Division (LSD) of the Institute of Advanced Study in Science and
Technology (IASST), Guwahati, India for future references.
Sample Preparation
Freshly collected plant (C. asiatica) was washed twice with
distilled water, dried at room temperature, powdered and used
for extraction. The dried plant powder (100 g) was dissolved in
1000 mL of distilled water for 72 h with occasional shaking. The
extract was further filtered through Whatman No. 1 filter paper
and the filtrate was concentrated using a bench top lyophilizer
under reduced pressure. The extract was stored at 4◦C until
further use in the designated experiment.
Chemicals and Reagents
Standards, such as DPPH, 2,2′-azinobis-3-ethyl benzothiazole-
6-sulfonic acid (ABTS), trolox, ascorbic acid and standard
hyperlipidemic drug, i.e., Fenofibrate and standard enzyme
used for catalase, SOD and diagnostic kits for measuring
TC, TG, high density lipoprotein- cholesterol (HDL-C), were
purchased from Sigma-Aldrich. Methanol (Fischer Scientific)
and ethyl acetate (Merck) were procured. Potassium ferricyanide,
Frontiers in Pharmacology | www.frontiersin.org 2 October 2016 | Volume 7 | Article 400
fphar-07-00400 October 26, 2016 Time: 13:44 # 3
Kumari et al. Anti-hyperlipidemic Properties of Centella asiatica (L.) Extract
trichloroacetic acid (TCA), ferric chloride, sodium nitroprusside,
naphthyl ethylenediamine dichloride, sulfanilamide, phosphoric
acid, sodium hydroxide, sodium chloride, hydrochloric acid,
ferrozine, and ferrous chloride were obtained from HiMedia
laboratory, India.
UHPLC-ESI Orbitrap MS/MS Analysis
The chromatographic separation was carried out using an
ultra-high performance liquid chromatography (UHPLC) system
coupled with an electron spray ionization (ESI) Orbitrap mass
spectrometer. A series of 3100 UHPLC system (Dionex, Inc.,
Sunnyvale, CA, USA) is equipped with a binary pump, a
degasser, an autosampler, a thermostated column compartment,
and control module. The chromatographic separation was on
a Hypersil Gold C18 column (1.9) operated at 25◦C. Gradient
chromatographic separation was performed for each extract of
the samples by using the previous method (Kumari et al., 2016).
The screening and identification of the phenolic compounds in
the C. asiatica extract were determined by using mass spectrum
and its unique fragmentation spectrum. The comparison of the
observed MS/MS spectra with those found in the literature and
mass bank database was the main tool for putative identification
of the phenolic compounds.
In vitro Measurement of Antioxidant
Properties
2, 2-Diphenyl -1- Picrylhydrazyl (DPPH) Radical
Scavenging Activity Assay
The free radical scavenging activity of the samples was
determined according to the method of Kumari et al. (2016).
A freshly prepared solution of DPPH in methanol (6 × 10−5
M) was used for the UV measurements. The samples of different
concentrations (4–64 µg/mL) were added to DPPH solution in
1:1 ratio followed by vortexing. Then, it was allowed to take place
in the dark at room temperature. Ascorbic acid and trolox were
utilized as a standard. The inhibition percentage of DPPH radical
scavenging activity was calculated using the following equation.
Inhibition(%) = [(A0 − A)/A0] × 100
Where, A0 is the absorbance of DPPH in the absence of the
sample and A is the absorbance of DPPH in the presence of the
sample.
The IC50 values (the concentration required to scavenge 50%
of the free radical) were estimated from a plot of % inhibition
against the concentration of the sample solutions.
Total Reduction Capability
The total reduction capability of samples was determined
according to the method of Kumari et al. (2016). 2.5 mL of
0.2 M phosphate buffer (pH 6.6) and 2.5 mL of 1% potassium
ferric cyanide were added to 1 mL of samples in different
concentrations (4–64 µg/mL), followed by gentle mixing. The
mixture was incubated at 50◦C in a water bath for 20 min. The
reaction was stopped by adding 2.5 mL of 10% TCA and the
mixture was centrifuged at 4000 rpm for 10 min. From the top
layer, 2.5 mL was transferred into the tube containing 2.5 mL
distilled water and 0.5 mL of 0.1% ferric chloride (FeCl3.6H2O),
mixed thoroughly. After 5 min, the absorbance was measured at
700 nm against blank. Trolox and ascorbic acid were taken as a
standard.
ABTS+ Radical Cation Decolorization Assay
The antioxidant activities of the extracts were determined by
the improved ABTS+ radical cation scavenging ability with the
slight modification (Re et al., 1999; Sarma et al., 2016). ABTS+
radical cation was produced by mixing 7 mM 2, 2′- azino-
bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt
(ABTS) and 2.45 mM potassium persulfate (K2S2O8), incubated
at room temperature in the dark. To determine the ABTS
radical scavenging activity, 3 mL of ABTS+ solution was mixed
thoroughly with 0.2 mL of different concentration (4–64 µg/mL)
of extracts. Ascorbic acid and trolox were taken as a standard.
The reaction mixture was allowed to stand at room temperature
for 6 min.
The percentage inhibition was calculated by the following
formula:
%Inhibition = OD of control− OD of sample/
OD of control × 100
Hydrogen peroxide (H2O2) Radical Scavenging
Activity
Hydrogen peroxide (H2O2) radical scavenging activities of the
extracts were determined according to the method of Sarma et al.
(2016). Briefly, water extracts of C. asiatica (4–64 µg/mL) were
added to 0.6 mL H2O2 (40 mM) with the prepared phosphate
buffer (pH 7.4). The reaction mixtures were incubated at room
temperature for 10 min. After the incubation, the reaction
mixture read at 230 nm against the blank solution with phosphate
buffer (pH 7.4). Ascorbic acid and trolox were taken as a standard.
The inhibition percentage was calculated based on the formula:
Percentage(%) of inhibition = (A1 − A2)/A1 × 100.
Where, A1- absorbance of the H2O2 and A2- absorbance of the
reaction mixture with extract.
Nitric Oxide (NO) Radical Scavenging Assay
Nitric oxide (NO) radical scavenging assay was carried out by
the method of Kumari et al. (2016). 0.6 mL of 10 mM sodium
nitroprusside was mixed with 1 mL of water extract of C. asiatica
in different concentration (4–64 µg/mL). The mixture was
incubated at 25◦C for 150 min, followed by mixing with 1.0 mL
of pre-prepared Griess reagent (1% sulfanilamide, 0.1% naphthyl
ethylenediamine dichloride, and 2% phosphoric acid). Ascorbic
acid and trolox were taken as a standard. The absorbance was
measured at 546 nm. The inhibition was calculated by the
following equation:
%inhibition of NO radical = [A0 − A1]/A0 × 100.
Where, A0 is the absorbance before the reaction and A1 is the
absorbance after the reaction has taken place with Griess reagent.
The decreasing absorbance indicates a high NO scavenging
activity.
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In vitro Lipid Peroxidation (LPO) Assay
Preparation of rat liver homogenate
Adult Wistar albino rats (150–200 g) were anesthetized with
sodium pentobarbitone (35 mg kg−1) followed by excision of
one lobe of the liver and washing with 0.9% NaCl solution.
Tissue homogenate was prepared in a ratio of 1 g wet tissue to
10 times (w/v) 0.05 M ice-cold phosphate buffer (pH-7.5) and
homogenized by using Teflon homogenizer. The homogenate
was used for the estimation of thiobarbituric acid reactive
substances (TBARSs).
TBARS assay
The LPO of C. asiatica extract was determined according to the
method of Kumari et al. (2016). Liver homogenate (0.25 mL)
was mixed with 0.1 mL Tris HCL buffer (pH 7.2), 0.05 mL of
0.1 mM ascorbic acid, 0.05 mL 4 mM FeCl2 solution and 0.05 mL
of the test extracts. All extracts were tested at five different
concentrations (4–64 µg/mL). The mixture was incubated at
37◦C for 1 h and then 1.5 mL 0.8% (w/v) 2- thiobarbituric
acid, 1.5 mL 20% acetic acid, and 0.2 mL 8.1% (w/v) sodium
dodecyl sulfate were added to the reaction mixture. The mixture
was made up to 4.0 mL with distilled water and heated at
95◦C for 60 min. After cooling with tap water, 1.0 mL distilled
water and 5.0 mL of a mixture of n-butanol and pyridine
(15:1, v/v) were added. The mixture was shaken vigorously. The
absorbance was measured at 532 nm in a spectrophotometer
(Beckman, UK). Ascorbic acid and trolox were taken as a
standard.
In vivo Study
Experimental Animals and Ethics Statement
All the experiments were conducted by using laboratory-
bred male Wistar albino rats at IASST, Guwahati, Assam,
in accordance with the internationally accepted guideline
for experimental animals use and the study was approved
by the Institute Animal Ethics Committee (IAEC)
(1706/GO/c/13/CPCSEA), IASST. All animals were housed
under controlled conditions of temperature (24 ± 3◦C), relative
humidity (60 ± 10%), 12/12 h. light–dark cycle, and water
ad libitum the animal house of the IASST. Wister rats (male)
weighing between 150 and 200 g were utilized for animal
experiments.
Acute Toxicity Study
Acute toxicity test was conducted in C3H mice (n= 6) following
the Organization for Economic Co-operation and Development
(OECD) protocol. The animals were kept fasting overnight except
water ad libitum and administered with a single dose of 5 mg/kg
body weight (b.w.) with under observation for a period of 14 days.
As per the protocol mandate, (i) if mortality was observed in two
out of three animals, then the dose administered was assigned
as toxic dose, (ii) If mortality took place for single out of three,
the dose was repeated to confirm the toxicity, (iii) if there was
no mortality at all, the dose specificity had been raised to the
maximum of 2,000 mg/kg b.w.
Induction of Hyperlipidemic, Experimental Design,
and Treatment Schedule
For the development of hyperlipidemic conditions, rats weighing
between 150 and 200 g were fed with high-cholesterol-diet
(HCD), consisting of cholesterol 2%, whole wheat 62.5 g, yellow
corn 37.5 g, barley, vitamin B12 one tablet. The cholesterol
solution was prepared under the requirement of 25 mg/kg b.w. of
rat by dissolving the cholesterol in refined groundnut oil (0.5%
w/v) (Khanna et al., 2002). Each individual animal was given
12 g of diet per day. All groups were subjected to intragastric
administration every day till 28 days. After allowing a week for
acclimatization, the rats were divided into six groups (six rats
per group). Group A: normal diet and water (control). Group B:
normal diet+ cholesterol (25 mg/kg b. w.)/day. Group C: normal
diet + cholesterol (25 mg/kg b.w./day) + fenofibrate (65 mg/kg
b.w./day). Group D: normal diet + cholesterol (25 mg/kg
b.w./day) + CAE1 (0.25 g/kg b.w./day). Group E: normal diet+
cholesterol (25 mg/kg b.w./day) + CAE2 (0.5 g/kg b.w./day).
Group F: normal diet+ cholesterol (25 mg/kg b.w./day) + CAE3
(1 g/ kg b.w./day) up to 28 days.
Collection of Heart, Liver, and Serum
At the end of the experiment, all feed was removed 14 h before
anesthesia. After being anesthetized, the heart, liver, kidney from
rat were removed and weighed. The livers were collected and
stored at −80◦C for further analyses. Blood samples were also
collected by an intracardiac puncture followed by separation of
serum from the blood samples and collection in heparinized
tubes. The collected serum samples were mixed gently by
inverting 2–3 times and incubation at 4◦C for 2–3 h. Plasma
was also separated from blood by centrifugation at 2500 rpm for
30 min, which was aliquoted and stored at 4◦C until further use
(Feng et al., 2015).
Preparation of Tissue Homogenate
Tissue homogenate (rat brain, liver, heart, and kidney) was
prepared in a ratio of 1 g of wet tissue to 10 times (w/v) 0.05 M
ice-cold phosphate buffer (pH 7.4) and homogenized by using
a Teflon homogenizer. 0.2 mL of homogenate was used for
estimation of TBARS. The remaining part of the homogenate was
divided into two parts, one part of which was mixed with 10%
TCA (1:1), centrifuged at 5000 rpm (4◦C, for 10 min) and the
supernatant was used for GSH estimation. The other part of the
homogenate was centrifuged at 15000 rpm at 4◦C for 60 min, the
supernatants were used for SOD estimation.
Biochemical Analysis
Blood lipid profile analysis
Total cholesterol, TG, and HDL-C in serum were determined
using test kits from Accurex Biomedical Pvt. Limited. Low
density lipoprotein cholesterol (LDL-C) and very low density
lipoprotein cholesterol (VLDL-C) were calculated using
Friedwald’s formula (Friedwald’s et al., 1972).
Evaluation of tissue markers of oxidative stress
Thiobarbituric acid reactive substances were measured as a
marker of lipid peroxidation for plasma, heart, and liver tissues
by using the procedure described by Ohkawa et al. (1979), while
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glutathione (GSH) by Ellman (1959) and superoxide dismutase
(SOD) (Marklund and Marklund, 1974). Nitrate/nitrites (NO)
level was assayed by using the method described by Green et al.
(1982).
Histopathological Evaluation
Rats were fed diets for 4 weeks. Upon termination of the
experiment, food was withheld from the rat for 24 h before
sacrifice. Rat were then anesthetized, and livers were immediately
excised, weighed and stored at 80◦C for further use, or fixed
in 10% buffered formalin at room temperature for histological
analysis. For hepatic histological examination, formalin-fixed
liver samples were embedded in paraffin, sectioned and stained
with hematoxylin and eosin (H&E), and subjected to light
microscope observation.
Statistical Analysis
The statistical analysis was carried out using the OriginPro 9.0
software packages (OriginLab Corporation, Northampton, MA,
USA) and the statistical Pearson’s correlation coefficients by using
the OriginPro 6.0 software packages (OriginLab Corporation,
Northampton, MA, USA). The results were determined by using
one-way ANOVA and p < 0.05 were set as significant. IC50 was
calculated using GraphPad PRISM, version 6.03 for windows
(GraphPad software). All the measurements were performed in
triplicate (n= 3). Mean values± SD were calculated.
RESULTS
Identification of Phenolic Compounds
The screening and identification of C. asiatica extract was
performed by UHPLC–ESI-MS/MS. The chromatographic runs
are illustrated in Figure 1 and Supplementary Figure S1. It
reveals the observation of intense peaks at 0–20 min. The peak
identification was performed by comparison of the retention time
(RT), λmax, and mass spectra of the C. asiatica with the standard
compounds and the earlier literature reports. Peaks with RTs
(min) of 1.62, 1.72, 1.87, 1.88, 2.24 (peaks 1–5) were identified as
the following: gulonic acid (RT 1.62, [M-H]- ion at m/z 195.81, λ
max 275 nm), ferulic acid (RT 1.72, [M-H]− ion at m/z 193.81, λ
max 275 nm), kaempferol (RT 1.87, [M+H]+ ion at m/z 287.89,
λ max 275 nm), chlorogenic acid (RT 1.88, [M-H]− ion at m/z
353.09, λ max 275 nm), and asiatic acid (RT 2.24, [M-H]− ion at
m/z 487.34, λ max 275 nm).
In vitro Antioxidant Activities
DPPH Radical Scavenging Activity
The reduction capability of DPPH radicals was determined by the
decrease in its absorbance at 517 nm induced by extracts having
antioxidant potential. It produced hydrazine by converting the
unpaired electrons to paired electron due to the hydrogen
donating ability of the extract (Ozsoy et al., 2008). As shown
in Figure 2A, at a concentration of 64 µg/mL, the IC50 values
of water extracts of C. asiatica, trolox, and ascorbic acid were
9.62 ± 0.88, 14.32 ± 1.6, and 6.93 ± 0.76 µg/mL, respectively.
In this present study, the IC50 value of C. asiatica extract was
demonstrated significantly higher free radical scavenging activity
compared to the standard, trolox while the lowering IC50 value
indicates a higher free radical scavenging activity (Figure 3).
Total Reduction Capability
The reducing ability of the extract was determined by the
methods (Ahmed et al., 2013; Kumari et al., 2016). The reduction
capability of the tested plant extract was increased with the
increasing concentration in trolox and ascorbic acid equivalent
as shown in Figure 2B. From the analysis, the absorbance
of C. asiatica at 64 µg/mL was 0.18 respectively. Trolox and
ascorbic acid were used as positive control and its reducing
power at 64 µg/mL were 0.21 and 0.28. The results showed a
concentration-dependent significant increase (p < 0.05) in the
reductive ability of the test samples. These results demonstrated
that C. asiatica extract had marked the difference in ferric ions
(Fe3+) reducing ability as compared to the ascorbic acid.
ABTS Radical Cation Decolourization Assay
The ABTS+ radical scavenging ability is an important method for
determining the antioxidant ability. ABTS, a protonated radical,
has characteristic absorbance maxima at 734 nm, which decreases
with the scavenging capacity (Wang et al., 1998). The results
from the ABTS+ radical scavenging ability was found to be high
in C. asiatica (IC50 = 27.21 µg/mL) followed by ascorbic acid
(IC50 = 12.06 ± 1.06 µg/mL) and trolox (12.76 ± 2.1 µg/mL)
(Figure 3). C. asiatica, ascorbic acid and trolox exhibited the
dose-dependent effective antioxidant activity (Figure 2C).
Hydrogen Peroxide (H2O2) Radical Scavenging
Activity
Hydroxyl radicals are extremely reactive free radicals formed
in the biological system and there is no any specific enzymes
to defend against them in human (Liu et al., 2005). The
scavenging ability of C. asiatica, ascorbic acid and trolox are
shown in Figure 2D. H2O2 radical scavenging ability of extracts
of C. asiatica, ascorbic acid and trolox at the concentration of
64 µg/mL were 59.93 ± 1.07, 69.96 ± 1.07, and 66.43 ± 1.4%,
respectively. The IC50 values of C. asiatica, ascorbic acid and
trolox found to be 18.23± 2.1, 7.6± 2.51, and 13.43± 1.4µg/mL,
respectively. The IC50 value indicates that the plant extract is a
better hydroxyl radical scavenger, which quite comparable with
the standard ascorbic acid and trolox (Figure 3). In our study, the
hydroxyl radical scavenging activity was increased by the extract
with increasing concentration.
Nitric Oxide (NO) Radical Scavenging Activity
From the analysis, the water extract of C. asiatica showed
the highest inhibitory effect with the IC50 value of
28.15 ± 2.01 µg/mL at the concentration of 64 µg/mL. In
contrast, trolox and ascorbic acid showed the inhibitory
effect with the IC50 value 18.53 ± 1.7, and 21.93 ± 3.2 µg/mL,
respectively (Figure 3). Therefore, NO radical scavenging activity
of C. asiatica was quite comparable to trolox and ascorbic acid
at the concentration of 64 µg/mL (Figure 2E). Earlier reports
demonstrate that the phenolic compounds play a vital role in
NO suppression, which might be the reason behind differential
inhibitory effect observed in this study (Kumari et al., 2016).
Frontiers in Pharmacology | www.frontiersin.org 5 October 2016 | Volume 7 | Article 400
fphar-07-00400 October 26, 2016 Time: 13:44 # 6
Kumari et al. Anti-hyperlipidemic Properties of Centella asiatica (L.) Extract
FIGURE 1 | Ultra-high performance liquid chromatography (UHPLC) chromatogram at 265, 354, 190–400 nm range of C. asiatica extract.
Inhibition of Lipid Peroxidation (LPO)
In this assay, LPO was significantly inhibited by plant extracts
in a dose-dependent manner (Figure 2F). The inhibition at
the concentration of 64 µg/mL is followed in the order,
C. asiatica < trolox < Ascorbic acid. C. asiatica showed the
highest inhibition of LPO with 60.53 ± 2.21% (p < 0.05), at the
concentration of 64µg/mL whereas trolox showed 75.66± 1.45%
of inhibitory effects. Additionally, ascorbic acid was also utilized
as a positive control significantly inhibited LPO by 78.93± 1.86%.
In addition, the IC50 values of C. asiatica, trolox, and ascorbic
acid were recorded to be 42.13 ± 2.32, 14.21 ± 1.01, and
10.31± 1.03 µg/mL, respectively (Figure 3). It has been reported
that phenolic compounds have shown more potential to prevent
LPO and the associated diseases (Kumari et al., 2016). The results
had clearly corroborated the efficacy of C. asiatica as a promising
source of inhibiting LPO.
Acute Toxicity and Effect of CAE on Body
Weight
The results of the acute oral administration of CAE in various
doses up to 2000 mg/kg indicated no mortality up to 15 days
after treatment. According to the acute toxicity studies of the
ethanolic extract of CAE at a dose ranging from 2 to 5 g per
kg body weight for 14 days did not manifest any significant and
noticeable signs of toxicity in rats. In this study, after 28 days,
the body weight of groups including normal or HCF feeding
was significantly affected. The changes in body weight are shown
in Table 2. The body weight was significantly increased in case
of HCF fed groups than rats subjected to normal conditions
(NCs) (two-way ANOVA, p < 0.05). However, the body weight
of hyperlipidemic rat treated with the three different dose
levels of CAE (CAE1 = 0.25 g/kg b.w./day, CAE2 = 0.5 g/kg
b.w./day, CAE3 = 1 g/kg b.w./day) demonstrated a remarkable
decrease compared to the HCF group (one-way ANOVA,
p < 0.05). This result was in agreement with previous work
by who observed a marked decrease in body weight in CAE
treated rats.
Biochemical Parameters
As shown in Table 3, serum lipids level (TC, TG, VLDL-C, and
LDL-C) were increased significantly in HCF group in comparison
to that of NC group (p < 0.05). Treatment with three different
dose levels of CAE(CAE1 = 0.25 g/kg b.w./day, CAE2 = 0.5 g/kg
b.w./day, CAE3 = 1 g/kg b.w./day)in the HCF diet significantly
lowered (p < 0.05) plasma TC by 35.7, 39.81, and 51.72%,
respectively and TG by 24.83, 32.15, and 38.83%, respectively
compared to the HCF groups. As far as the serum, treatment with
CAE1, CAE2, and CAE3 elevated the HDL-C level and decline in
the LDL-C contents. It was noted that CAE exhibited comparable
potencies with those of fenofibrate on lipid parameters. Several
studies have shown that TC, TC, TG, VLDL-C, and LDL-C level
as biomarkers for hyperlipidemia (Stein and Stein, 1999; Devi and
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FIGURE 2 | Antioxidant activity of C. asiatica extract at different concentration (4–64 µg/mL). (A) 2-2- Diphenyl-1-picryl-hydrazyl (DPPH) free radical
scavenging activity. (B) Total reductive capability. (C) ABTS radical radical-scavenging ability. (D) H2O2 radical scavenging activity. (E) Nitric oxide (NO)
radical-scavenging ability. (F) Lipid peroxidation assay. Each point represents the mean ± SD (n = 3). ∗∗∗, ∗∗, and ∗ shows statistical significant differences at
p < 0.001, p < 0.01, and p < 0.05.
FIGURE 3 | The IC50 (µg/mL) values of C. asiatica extracts for free
radical scavenging activity by DPPH, ABTS, H2O2, NO, and LPO
radical (Lower IC50 value indicates higher antioxidant activity).
Sharma, 2004). In this present work, CAE also improved the lipid
profile, which was quite comparable with other studies (Stein and
Stein, 1999; Devi and Sharma, 2004).
Oxidative Stress Markers
In hyperlipidemic condition, enzymatic as well as non-enzymatic
antioxidative defense system such as SOD and reduced GSH
are altered leading to reactive oxygen species (ROS) mediated
damage (Devi and Sharma, 2004). As shown in Table 4, the
OS markers (SOD, GSH, TBARS, and NO) levels increased
significantly (p < 0.05) in serum, heart, and liver of HCF rats in
comparison to that of NC group.
Heart
The level of SOD and GSH decreases significantly (p < 0.05)
in stress induced HCF group heart tissue by 45 and 26.2%,
respectively when compared with those of NC groups.
CAE treatment groups prevented the alterations in SOD
and GSH levels in HCF group heart tissue homogenates,
however, CAE1, CAE2, and CAE3 treatment group significantly
increase (p < 0.01) the serum SOD level by 60.2, 70.3, and
78.1%, respectively. In addition, CAE1, CAE2, and CAE3 and
TABLE 1 | Pearson’s correlation coefficients between the five assays.
DPPH ABTS+ H202 NO LPO
ABTS+ 0.969∗ – 0.996∗∗∗ 0.997∗∗∗ 0.937∗
H202 0.965∗∗ 0.996∗∗∗ – 0.988∗∗∗ 0.942∗∗
DPPH – 0.969∗ 0.965∗ 0.965∗ 0.991∗∗∗
NO 0.965∗ 0.997∗∗∗ 0.988∗∗∗ – 0.926∗
LPO 0.991∗∗ 0.937∗ 0.942∗ 0.926∗ –
∗Correlation is significant at the 0.05 level.
∗∗Correlation is significant at the 0.01 level.
∗∗∗Correlation is significant at the 0.001 level.
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TABLE 2 | Effect of various extracts of CAE (Centella asiatica extract) on
body weight (b.w.) gram (g) in HCF- induced rats.
Different group Initial body weight
(1st day)
Final body weight
(28th day)
NC 173.5 ± 2.21 180.2 ± 3.53
HCF 188.2 ± 2.85 208.1 ± 3.44
HCF+FF 177.2 ± 4.23 182.3 ± 3.31
HCF+CAE1 175.3 ± 3.43 189.2 ± 2.73
HCF+CAE2 178.22 ± 2.11 187.3 ± 3.51
HCF+CAE3 175.22 ± 3.41 184.41 ± 2.97
CAE, Centella asiatica extract; NC, normal control; HCF, high cholesterol-fed;
HCF+FF, high cholesterol-fed + fenofibrate; HCF+CAE1, high cholesterol-fed +
Centella asiatica extract1 (0.25 g/kg b.w./day); HCF+CAE2, high cholesterol-fed +
Centella asiatica extract2 (0.5 g/kg b.w./day); HCF+CAE3, high cholesterol-fed +
Centella asiatica extract3 (1 g/kg b.w./day).
significantly increases (p < 0.01) the GSH level by 35.2, 45.5,
and 48.3%, respectively. However, there were no significant
differences in the other measured parameters.
Serum
In serum of HCF rat, the SOD level decreases significantly
(p < 0.01) by 39.34% compared with those of NC group. CAE3
treatment group significantly increases (p< 0.01) the serum SOD
level by 65.4%. However, CAE1 and CAE2 treatment did not
incorporate any significant changes in serum SOD parameters.
However, there were no significant differences were detected in
the other measured parameters.
Liver
The level of SOD and GSH were decreased significantly (p< 0.05)
and TBARS increase significantly (p< 0.05) in liver homogenates
of HCF group when compared with those of the NC group. CAE1,
CAE2, and CAE3 treatment groups prevented the alterations in
the level of SOD and GSH in HCF group. CAE1, CAE2, and
CAE3 increases the SOD (30.21, 45.1, and 47.12%) and GSH
(23.3, 30.21, and 37.23) level. TBARS level decreases significantly
(p < 0.05) by 55.59%. No changes were observed in the level of
NO in CAE treated groups.
Histopathological Observations in Liver
Tissue Sections
To further investigate hepatocyte morphological changes during
the function of CAE, liver tissue sections using histopathological
microscopy were examined. As shown in Figure 4, after 28 days
of treatment with CAE, the liver cell structure of HCF rats in the
high dose CAE treated group was integrated. The sizes of lipid
droplets in the CAE group were remarkably smaller than those of
HCF group, suggesting that CAE could reduce the accumulation
of lipid droplets. In the present study, these data directly confirm
that CAE treatment group can keep hepatocytes normal by
preventing or reducing excess lipid formation in HCF rat.
DISCUSSION
The findings of this study demonstrated the antioxidant and anti-
hyperlipidemic ability of extracts of C. asiatica by several in vitro
and in vivo methods. The experimental results showed that
extract of C. asiatica showed strong DPPH scavenging activity.
Earlier reports demonstrated the IC50 value of C. asiatica in
DPPH radical scavenging assay was in the range of 31.25 µg/mL
(Pittella et al., 2009; Ahmed et al., 2013). However, in this study,
the IC50 value of C. asiatica in DPPH radical scavenging assay
was far lower (∼8 µg/mL) in comparison with the previous
report (Pittella et al., 2009; Ahmed et al., 2013). Several previous
reports demonstrated that the presences of the antioxidants in
the extract were determined by assessing the ability of extract to
reduce the ferric cyanide complex to the ferrous form (Ahmed
et al., 2013; Kumari et al., 2016). The reducing power of a
compound may serve as a significant indicator of its potential
antioxidant activity (Pal et al., 2011). Samples with higher
reducing power have better abilities to donate the electron and
the free radical form stable substances by accepting the donated
electrons, resulting in the termination of radical chain reaction
(Deori et al., 2014). In our previous report, the polyphenolic
compounds of C. asiatica showed significantly reduced the ferric
cyanide complex to the ferrous form (reducing capabilities) at
higher concentrations (Kumari et al., 2016). In the present study,
the reducing ability of the extracts of C. asiatica was quite
comparable (Figure 2B) with previous studies (Ahmed et al.,
2013; Kumari et al., 2016). The previous report confirmed that
the hydroxyl radicals are extremely reactive free radicals formed
in the biological system and there are no any specific enzymes to
defend against them in human (Liu et al., 2005). The presence
of hydroxyl radical in the body may lead to the oxidative DNA
damage. Therefore, it is very important to find the solution
using natural products with good scavenging activity against this
TABLE 3 | Effect of various extracts of CAE (C. asiatica extract) on rats’ serum lipid profile.
Parameters (mg/dL) NC HCF HCF+FF HCF+CAE1 HCF+CAE2 HCF+CAE3
TC 75.04 ± 3.23 162.52 ± 5.5++ 126.55 ± 6.6∗ 104.4 ± 3.21∗ 97.69 ± 3.42∗ 78.43 ± 2.46∗∗
TG 64.47 ± 3.31 117.7 ± 4.11+ 97.34 ± 4.47 88.47 ± 3.2 79.85 ± 2.03∗ 72.01 ± 2.46∗∗
HDL 64.69 ± 3.42 36.55 ± 4.91+ 42.73 ± 2.12 57.30 ± 3.2 59.03 ± 4.21∗ 60.71 ± 5.11∗
LDL 53.2 ± 2.3++ 138.92 ± 4.2++ 83.54 ± 7.21 58.13 ± 5.6∗ 56.41 ± 3.29∗ 54.73 ± 3.45∗∗
VLDL 16.83 ± 2.72 26.37 ± 3.96+ 21.44 ± 3.94 19.23 ± 2.1 18.78 ± 1.03 15.41 ± 2.33∗
CAE, Centella asiatica extract; NC, normal control; HCF, high cholesterol-fed; HCF+FF, high cholesterol-fed + fenofibrate; HCF+CAE1, high cholesterol-fed + Centella
asiatica extract1 (0.25 g/kg b.w./day); HCF+CAE2, high cholesterol-fed + Centella asiatica extract2 (0.5 g/kg b.w./day); HCF+CAE3, high cholesterol-fed + Centella
asiatica extract3 (1 g/kg b.w./day).
∗p < 0.05 vs. HCF group, ∗∗p < 0.01 vs. HCF group, +p < 0.05 vs. NC group, ++p < 0.01 vs. NC group. n = 6, mean ± SEM.
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TABLE 4 | Changes in oxidative stress markers (SOD, CAT, GSH, TBARS, and NO) in heart, liver, and serum.
Parameters NC HCF HCF+FF HCF+CAE1 HCF+CAE2 HCF+CAE1
Heart SODa 69.45 ± 3.4 38.16 ± 1.15+ 65.39 ± 2.26 61.16 ± 0.01 64.99 ± 1.5 67.99 ± 1.5∗
GSHb 112 ± 5.6 60 ± 3.2++ 80 ± 4 81.82 ± 2.7∗ 87 ± 6.1∗∗ 89 ± 6.21∗∗
TBARSc 35.2 ± 1.6 52.32 ± 7.2+ 41.1 ± 2.3 39.2 ± 3.2 38.61 ± 2.5 38.18 ± 2.1
NOd 15.18 ± 1.34 27.14 ± 1.32 17.74 ± 1.31 21.32 ± 2.21 17.21 ± 1.0 13.21 ± 1.0
Liver SODa 86.35 ± 1.21 55.14 ± 1.11+ 79.26 ± 1.03 70.31 ± 1.12 79.96 ± 2.2 81.16 ± 1.2∗∗
GSHb 350 ± 10 258 ± 6.5+ 344 ± 4.5 318.17 ± 8.5 336 ± 6.7 356 ± 6.6∗
TBARSc 76.4 ± 5.3 187.2 ± 7.1++ 147.57 ± 8.1 116.2 ± 6.7 97.66 ± 7.230.6 82.4.7 ± 6.7∗∗
NOd 21.47 ± 2.31 47 ± 3.26 23.64 ± 2.43 33.34 ± 2.7 5 ± 2.5 24.65 ± 0.5
Serum SODa 32.13 ± 1.13 19.49 ± 2++ 22.43 ± 1.7 26.56 ± 5.23 28.32 ± 4.2 32.25 ± 2.1∗∗
GSHe 132 ± 5.3 201 ± 7.3 104 ± 4 114.89 ± 2.7 124.5 ± 5 130.2 ± 7.5
TBARSf 29.2 ± 1.4 46.92 ± 3.6 37.37 ± 4.2 33.1 ± 2.27 27.62 ± 1.9 28.81 ± 2.1
NOg 26.63 ± 1.51 56.56 ± 1.21 23.82 ± 1.51 39.51 ± 2.12 33.19 ± 1.1 25.23 ± 4.3
CAE, Centella asiatica extract; NC, normal control; HCF, high cholesterol-fed; HCF+FF, high cholesterol-fed + fenofibrate; HCF+CAE1, high cholesterol-fed + Centella
asiatica extract1 (0.25 g/kg b.w./day); HCF+CAE2, high cholesterol-fed + Centella asiatica extract2 (0.5 g/kg b.w./day); HCF+CAE3, high cholesterol-fed + Centella
asiatica extract3 (1 g/kg b.w./day).
a% Inhibition, bµg/mg, cµM/mg, dµM/mg, eµg/mL, fµM/ mL, gµM/ mL. ∗p < 0.05 vs. HCF group, ∗∗p < 0.01 vs. HCF group, + p < 0.05 vs. NC group, ++p < 0.01
vs. NC group. n = 6, mean ± SEM.
FIGURE 4 | Histopathological effects of C. asiatica extracts (CAE) in liver of High cholesterol-fed (HCF) rat (A) Represents Hematoxylin Eosine
staining of normal liver with glomerulus. (B) High cholesterol-fed (HCF) liver with large area of necrosis, congested central vein (CV) and lipid droplets (LD)
accumulation. (C) Fenofibrate treated liver showing restoration of hepatic structure. (D) CAE1 (0.25 g/kg) treated liver; (E) CAE2 (0.5 g/kg) treated liver; (F) CAE3
(0.1 g/kg) treated liver; depicting improvement in the hepatic structure and sufficient reduction in the appearance of LD.
ROS. Earlier report also demonstrates that the scavenging of
hydroxyl radical is an important antioxidant activity because of
very high reactivity of the OH radical (Wang et al., 2008). In
our study, each extract showed an increase in hydroxyl radical
scavenging activity with increasing concentration of sample
extracts. Overproduction of NO causes cancer, inflammation,
neurodegenerative, chronic inflammatory diseases, ischemia-
reperfusion and other pathological conditions (Moncada et al.,
1991; Bajpai et al., 2014). Earlier reports demonstrate that
phenolic compounds play a vital role in NO suppression, which
might be the reason behind the differential inhibitory effect,
observed in this study (Kumari et al., 2016). In the present study,
the extracts scavenging the NO which results in the reduction of
chromophore formation, and decreases the absorbance with the
increase in extract concentrations. We further confirm that the
ABTS+ radical scavenging activity of the extract of C. asiatica
showed a good radical scavenging capacity with low IC50 value.
LPO involves the generation of free radical and hydroxyl radical
are the major active oxygen species causing LPO and enormous
biological damage (Chidambaram et al., 2013). It is believed that
LPO is one of the major causes of cardiovascular disease and
cancer, generating malondialdehyde (MDA) like product during
through a set of chemical reaction (Atmani et al., 2009). In the
present study, LPO was significantly inhibited by all the extracts
a dose-dependent manner. The inhibition at the concentration of
64 µg/mL followed order; C. asiatica < trolox < Ascorbic acid.
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The results had clearly corroborated the efficacy of C. asiatica as a
promising source of inhibiting LPO. Earlier study demonstrated
that the strong correlation between DPPH and ABTS methods
(Floegel et al., 2011). In the present study, Table 1 shows the
correlation between the five assays. DPPH was significantly and
positively correlated with ABTS+, H2O2, NO, and LPO. In the
cases of H2O2, indicates strongly correlated with ABTS+ and NO.
Additionally, ABTS+ and NO were significantly correlated with
H2O2, but not DPPH and LPO.
Elevation of LDL-C and TC and reduction of high density
lipoprotein level is associated with progression of atherosclerotic
lesions (Harrison et al., 2003; Minhajuddin et al., 2005; Jain
et al., 2007). In various studies, it has been reported that HCF
rat significantly increased (p < 0.05) the levels of TC, HDL,
LDL, VLDL, TGs, and also significantly decreased the level of
HDL in the serum (Devi and Sharma, 2004). In this present
work, CAE also improved the lipid profile, which was quite
comparable with other studies (Stein and Stein, 1999; Devi and
Sharma, 2004). In hyperlipidemic condition, enzymatic as well
as non-enzymatic antioxidative defense system such as SOD
and reduced GSH is altered leading to ROS mediated damage
(Devi and Sharma, 2004). As shown in Table 4, the OS markers
(SOD, GSH, TBARS, and NO) levels increased significantly
(p < 0.05) in serum, heart, and liver of HCF rats in comparison
to that of NC group. Earlier report also demonstrates that
hypercholesterolemia diminishes the antioxidant defense system
and decreases the activities of SOD and catalase in rats (Fki et al.,
2005). Enzymes such as SOD and catalase which contribute to
the antioxidant defense mechanism (Lee et al., 2002). However,
in the present investigation, treatment with CAE increases the
efficiency of SOD and GSH. Taken together, our result suggested
that the administration of CAE could improve the efficiency of
SOD and GSH. Furthermore, the previous report demonstrates
that there is an increase of TBARS in the animal fed with a high
cholesterol diet (Jiang et al., 2015). In addition, the decreased in
the activity of these antioxidants can lead to an excess availability
of superoxide anion and H2O2 in biological systems, which
in turn generate hydroxyl radicals resulting in initiation and
propagation of LPO (Kumuhekar and Katyane, 1992). In the
present study, the similar increasing trend in TBARS level in
HCF rat was observed. Herein, there was the preventive effect
on the lipid peroxidation level by treatment with CAE extract.
Earlier report also demonstrates that lipid drops are usually
accumulated in hepatic tissue, called hepatic steatosis, under
the progress of atherosclerosis, especially hyperlipidemia stage.
However, enzymes such as SOD and catalase which contribute
to the antioxidant defense mechanism and reducing excess lipid
drops (Lee et al., 2002; Devi and Sharma, 2004). In the present
study, these data directly confirm that CAE treatment group can
keep hepatocytes normal by preventing or reducing excess lipid
formation in HCF rat.
CONCLUSION
In this study, we have evaluated the antioxidant and anti-
hyperlipidemic ability of extracts of C. asiatica. Herein, C. asiatica
showed promising antioxidant and -antihyperlipidemic activities
and also exhibited the highest phytochemical contents. The
results of the present study indicate the presence of strong
phenolic antioxidants components mainly gulonic acid, ferulic
acid, kaempferol, chlorogenic acid, and asiatic acid in C. asiatica
extract as evidenced from UHPLC-MS/MS. Additionally, CAE
is capable of exhibiting significant anti-hyperlipidemic activities
in HCF induced rat by enhancing parameters like antioxidant
enzyme, body weight, and decrease serum lipid levels as
well as regeneration of hepatic structures. Moreover, the
CAE exerted to improve the hyperlipidemia induced hepatic
structures by reducing OS, and restoring the antioxidant
capacities. Taken together, this study strongly suggests that
the CAE treatment might be an efficient way for treatment
hyperlipidemia. This study has provided more evidence for
the use of C. asiatica as a promising traditional medicine
in the therapy of hyperlipidemia. Thus, these plant leaf
extracts may be utilized as natural agents in food and
pharmaceutical industries. Further studies are needed to
isolate and identify the bioactive compounds present in the
plant extracts and for the elucidation of their molecular
mechanisms.
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